Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics
Reference41 articles.
1. Ali HI, Fujita T, Akaho E, Nagamatsu T (2010) A comparative study of AutoDock and PMF scoring performances, and SAR of 2-substituted pyrazolotriazolopyrimidines and 4-substituted pyrazolopyrimidines as potent xanthine oxidase inhibitors. J Comput Aided Mol Des 24:57–75
2. Becker MA, Kisicki J, Khosravan R, Wu J, Mulford D, Hunt B, MacDonald P, Joseph-Ridge N (2004) Febuxostat (TMX‐67), a novel, non‐purine, selective inhibitor of xanthine oxidase, is safe and decreases serum urate in healthy volunteers. Nucl Nucl Nucl 23:35–40
3. Becker M, Schumacher H, MacDonald PA (2007) Febuxostat: a guide to its use in chronic hyperuricaemia. Abstr no 757 Arthritis Rheum 56(9 Suppl):S322
4. Biagi G, Giorgi I, Pacchini F, Livi O, Scartoni V (2001) 2-Alkyloxyalkylthiohypoxanthines as new potent inhibitors of xanthine oxidase. Farmaco 56:809–813
5. Borges F, Fernandes E, Roleira F (2002) Progress towards the discovery of xanthine oxidase inhibitors. Curr Med Chem 9:195–217
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A comprehensive review of synthetic and semisynthetic xanthine oxidase inhibitors: identification of potential leads based on in-silico computed ADME characteristics;Molecular Diversity;2024-08-20
2. Design, synthesis and anti-oxidant activities of novel 1,2,3,4-tetrazine, 1,2,3-triazoles and coumarin derivatives and their nanoparticular encapsulation;Nano Express;2024-07-30
3. Pathology, target discovery, and the evolution of XO inhibitors from the first discovery to recent advances (2020–2023);Bioorganic Chemistry;2024-02
4. Triazole derivatives as potential xanthine oxidase inhibitors: Design, enzyme inhibition potential, and docking studies;Archiv der Pharmazie;2024-01-09
5. Heterocyclic compounds as xanthine oxidase inhibitors for the management of hyperuricemia: synthetic strategies, structure–activity relationship and molecular docking studies (2018–2024);RSC Medicinal Chemistry;2024